Join us this March for the first ever CURE Patient-Focused Sessions, taking place at the Miami Breast Cancer Conference! 

To start your customized experience click the start button
Customize ?  
Cancer Types
Quick Links
Award Programs
About Us
Contact Us
Privacy Policy
Terms & Conditions
Face Book
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Pancreatic Cancer

Feature Video
Pancreatic cancer may be one of the more difficult cancers to be diagnosed with. This program discusses the risk factors, symptoms, and different treatments available to patients with pancreatic cancer as well as firsthand experiences and advice from a Pancreatic patient and her husband.
A leader of the Pancreatic Cancer Action Network, which aims to double survival rates by 2020, outlines treatment strategies that could lead to success.
Silas Inman
“Disease control is key in our patients with locally advanced disease, as it may lead to opportunities for additional treatment interventions, including radiotherapy, or even, in some favorable cases, surgical resection,” said lead study author Pascal Hammel, M.D., Ph.D.
Katie Kosko
“There have been significant developments in our underpinnings for the development of pancreas cancer on both a molecular and genetic basis," said Eileen M. O'Reilly, M.D.
Katie Kosko
Nutrition plays a crucial role in the lives of people with cancer. But more than a million people suffering from the disease in the United States also endure a wasting syndrome called cachexia.
Gina Columbus
What role will immunotherapy play in the future treatment of GI cancers? CURE spoke to Brian Hemphill, M.D., to find out. 
Beth Fand Incollingo
Experimental treatment uses engineered T cells to target prostate stem cell antigen.
A regimen without gemcitabine had promising survival rates for patients with metastatic pancreatic cancer, according to a recent study.
Wayne Kuznar
There were promising results when Abraxane was added to standard therapy to treat pancreatic cancer.
Katie Kosko
CURE spoke with Jason Luke, M.D., about some of the pressing topics in the field of immunotherapy.
Katie Kosko
A recent study found that taking asprin daily may reduce the chance of developing pancreatic cancer.

Sign In

Not a member? Sign up now!
Continue without login

Sign Up

Patient Caregiver Advocate Other